COMMUNICATIONS
(CH2Cl2): nÄ(CO) 2004 (vs), 1947 (sh), 1931 cm 1 (vs). 3: MS (FAB ,
Photomodulation of the Conformation of
Cyclic Peptides with Azobenzene Moieties in
the Peptide Backbone**
CH2Cl2): m/z (%): 968 (100) [M ], 791 (92) [M
Cptt]; IR (CH2Cl2):
nÄ(CO) 2023 (vs), 1954 cm (vs); 1H NMR (300 MHz, CDCl3,
258C): rotamer 3a: d 7.18 (d, J(H,H) 2.4 Hz, 2H, H4 and H5),
6.60 (t, J(H,H) 2.4 Hz, 1H, H2), 5.94 (d, J(H,H) 2.4 Hz, 2H, H4
and H5), 5.83 (t, J(H,H) 2.4 Hz, 1H, H2, Cptt), 4.42 and 4.19 (m, 2H
1
Raymond Behrendt, Christian Renner,
Michaela Schenk, Fengqi Wang, Josef Wachtveitl,
Dieter Oesterhelt, and Luis Moroder*
each, CH, cod), 2.7 ± 2.4 (m, 2H), 1.9 ± 2.2 (m, 4H), 1.8 ± 1.6 (m, 2H,
CH2, cod), 1.32 and 1.26 (s, 18H each, Cptt); rotamer 3b: d 6.69 and
6.38 (t, J(H,H) 2.4 Hz, 1H each, H2), 6.03 and 5.90 (d, J(H,H)
tt
2.4 Hz, 2H each, H4 and H5, Cp ), 4.42 and 4.19 (m, 2H each, CH,
For photomodulation of conformational, physico-chemical,
and biological properties of peptides, proteins, and phospho-
lipids large use has been made of the cis/trans isomerization of
azobenzene moieties grafted to specific sites of such bioma-
terials or related model systems.[1, 2] Since the light-induced
isomerization of azobenzene is accompanied by significant
changes in geometry and polarity of the chromophore,[3] this
proved to be well suited for induction of local topochemical
changes in conformationally more restricted small sys-
tems.[4±10] Low-mass cyclic peptides are rigid structures that
are extensively exploited for the design of libraries of
conformers of defined bioactivities.[11, 12] Thus, incorporation
of the azobenzene moiety into the peptide backbone of such
cyclic peptides is expected to represent an ideal system to
probe the efficiency of this ªlight-switchº for induction of
conformational transitions. With 4-(4-aminophenylazo)benz-
oyl (APB) as amino acid residue in the peptide backbone we
succeeded in the present study to construct a very rigid,
conformationally constrained cyclic peptide in the trans
configuration which upon irradiation, relaxes into a largely
free conformational space.
The distance between the two para-carbon atoms of the
azobenzene unit in the trans configuration is 9 and in the cis
configuration 5 . To transfer optimally these changes in
geometry to the peptide backbone, H-APB-OH was synthe-
sized according to known methods[13] and fully characterized
in its photochemical properties.[14, 15] It was then incorporated
into an octapeptide related to the active site of thioredoxine
reductase (Scheme 1). Owing to the low nucleophilicity of the
para-amino group of H-APB-OH, its protection in acylating
the resin-bound peptide was not required, but difficulties
were encountered in the subsequent acylation of this group.
These were overcome by silylation and using the acid fluoride
method for the peptide-chain extension step. Mild acidic
cleavage from the resin produced the linear side chain
protected pseudo-nonapeptide 1, which was then cyclized by
the PyBOP/HOBt/DIEA procedure. Final acidic deprotec-
tion generated the target compound 2 cyclo(Ala-Cys(StBu)-
Ala-Thr-Cys(StBu)-Asp-Gly-Phe-APB).
cod), 2.7 ± 2.4 (m, 2H), 2.2 ± 1.9 (m, 4H), 1.8 ± 1.6 (m, 2H, CH2 cod),
1.31 and 1.30 (s, 18H each, Cptt); 13C{1H} NMR (75 MHz, CDCl3,
258C): rotamer 3a: d 177.7 (CO), 150.0 and 142.2 (C1 and C3), 127.6
(C2), 119.7 (C4 and C5), 110.0 (C2), 105.5 (C4 and C5, Cptt), 84.0 and
80.6 (d, J(Rh-C) 11.5 Hz, CH, cod), 34.8 and 34.0 (CMe3), 32.7 and
31.8 (CH3, Cptt), 31.7 and 30.6 (CH2, cod); rotamer 3b: d 178.3
(CO), 147.2 and 147.1 (C1 and C3), 123.8 and 120.7 (C2), 109.5 and
tt
108.8 (C4 and C5, Cp ), 85.9 and 80.6 (d, J(Rh,C) 11.5 Hz, CH,
cod), 34.5 and 34.4 (CMe3), 32.3 and 32.2 (CH3, Cptt), 31.6 and 30.2
(CH2, cod). 4: 1H NMR (300 MHz, CDCl3, 258C): d 6.72 and 6.62 (t,
J(H,H) 2.5 Hz, 1H each, H2), 6.16 and 6.11 (d, J(H,H) 2.5 Hz, 2H
each, H4 and H5), 1.31 and 1.30 (s, 18H each, Cptt); 13C{1H} NMR
(75 MHz, CDCl3, 258C): d 184.9 (d, J(Rh,C) 74 Hz, CO), 175.4
(CO), 149.4 and 149.1 (C1 and C3), 126.2 and 122.5 (C2), 110.1 and
110.0 (C4 and C5), 34.9 and 34.8 (CMe3), 32.2 (CH3, Cptt); MS (FAB ,
CH2Cl2): m/z (%): 916 (46) [M ], 860 (100) [M
2CO], 739 (49)
Cptt]; IR (CH2Cl2): nÄ(CO) 2062 (s), 2031 (s), 1996 (m),
[M
1971 cm 1 (m).
[9] P. Kalck, C. Serra, C. Machet, R. Broussier, B. Gautheron, G. Delmas,
Â
G. Trouve, M. Kubicki, Organometallics 1993, 12, 1021.
[10] Crystal data for 3: C36H54IrO2RhS2Zr, Mr 969.24, monoclinic, space
group P21/c; a 11.9123(9), b 21.5742(17), c 15.0796(12) , b
3
105.526(2)8, V 3734.0(5) 3, Z 4, 1calcd 1.724 gcm
,
m
1
4.407 mm
.
Crystal dimensions 0.12 Â 0.16 Â 0.18 mm. Bruker
SMART CCD diffractometer, T 153(1) K, graphite-monochromat-
ed MoKa radiation (l 0.71073). A complete hemisphere of data was
scanned on w (0.308 per frame) with a run time of 20 s at the detector
resolution of 512 Â 512 pixel. Reflections were extracted by using the
SAINT program, and Lorentzian, polarization, and absorption
corrections were applied. Of 9398 reflections measured, 4506 were
unique (Rint 0.0657). The structure was solved by direct methods
(SHELXS-97) and refined by full-matrix least squares on F 2
(SHELXL-97). Anisotropic displacement parameters were used for
all non-hydrogen atoms. Hydrogen atoms were included in calculated
positions. 403 parameters, 18 restraints; R 0.0509 (3512 reflections,
F ꢀ 4sFo), Rw(F 2) 0.1007 (all reflections), and S 1.076. Max.
3
residual electron density 1.05 e close to the Ir atom. Crystallo-
graphic data (excluding structure factors) for the structure reported in
this paper have been deposited with the Cambridge Crystallographic
Data Centre as supplementary publication no. CCDC-116623. Copies
of the data can be obtained free of charge on application to CCDC, 12
Union Road, Cambridge CB21EZ, UK (fax: (44)1223-336-033;
e-mail: deposit@ccdc.cam.ac.uk).
[11] A. A. Del Paggio, E. L. Muetterties, D. M. Heinekey, V. W. Day, C. S.
Day, Organometallics 1986, 5, 575.
[12] F. H. Antwi-Nsiah, O. Oke, M. Cowie, Organometallics 1996, 15, 1042.
[13] R. McDonald, M. Cowie, Inorg. Chem. 1990, 29, 1564.
[14] Z. Tang, Y. Nomura, Y. Ishii, Y. Mizobe, M. Hidai, Organometallics
1997, 16, 151.
Peptides 1 and 2 were characterized spectroscopically
(Table 1). Compared to H-APB-OH [lmax 420 nm (p ± p*)
[15] a) I. F. Urazowski, V. I. Ponomaryov, O. G. Ellert, I. E. Nifantꢁev,
D. A. Lemenovskii, J. Organomet. Chem. 1988, 356, 181; b) W. A.
[*] Prof. Dr. L. Moroder, Dipl.-Chem. R. Behrendt, Dr. C. Renner,
Dr. M. Schenk, Dr. F. Wang, Prof. Dr. D. Oesterhelt
Max-Planck-Institut für Biochemie
Á
King, S. Di Bella, A. Gulino, G. Lanza, I. L. Fragala, C. L. Stern, T.
Marks, J. Am. Chem. Soc. 1999, 121, 355.
[16] C. H. Winter, D. A. Dobbs, X.-X. Zhou, J. Organomet. Chem. 1991,
403, 145.
[17] a) J. Okuda, J. Organomet. Chem. 1988, 35b, C43; b) C. H. Winter,
X.-X. Zhou, M. J. Heeg, Inorg. Chem. 1992, 31, 1808.
Am Klopferspitz 18A, D-82152 Martinsried (Germany)
Fax : ( 49)89-8578-2847
Dr. J. Wachtveitl
Institut für Medizinische Optik der Universität
Oettingenstrasse 67, D-80538 München (Germany)
[**] The study was supported by the SFB 533 (grant A8 Moroder/
Oesterhelt).
Angew. Chem. Int. Ed. 1999, 38, No. 18
ꢀ WILEY-VCH Verlag GmbH, D-69451 Weinheim, 1999
1433-7851/99/3818-2771 $ 17.50+.50/0
2771